戴維醫療(300314.SZ)捐贈143.1萬元用於支持抗擊新型冠狀病毒肺炎疫情
格隆匯2月3日丨戴維醫療(300314.SZ)公佈,當前,新型冠狀病毒肺炎疫情防控形勢嚴峻,公司高度關注疫情發展,在做好自身防控工作的同時,積極履行上市公司社會責任,公司於2020年02月03日向象山縣慈善總會捐贈100萬元現金以及價值43.1萬元的輸液泵等醫療物資,合計143.1萬元,專項用於支持抗擊新型冠狀病毒肺炎疫情。
公司此次對外捐贈是為了支持抗擊肺炎疫情,符合公司積極承擔社會責任的要求,有利於提升公司社會形象,此次對外捐贈來源為公司自有資金及自產與外購醫療器械產品,對公司當期及未來經營業績不構成重大影響,亦不會對投資者利益構成重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.